Early experience of a new extracorporeal carbon dioxide removal device for acute hypercapnic respiratory failure

ECCO2R Education

In this retrospective review, Dr. Ravindranath Tiruvoipati, et al. report their experience treating COPD, ARDS, asthma and bronchiolitis obliterans syndrome patients with the Hemolung RAS in three Australian ICUs (15 patients in total). This article was published in the December 2016 issue of the Critical Care and Resuscitation Journal.

Link to full text article: